Home healthcare equipment provider Apria prices IPO at $20 midpoint

Apria, which provides home healthcare equipment and services in the US, raised $150 million by offering 7.5 million shares (100% secondary) at $20, within the range of $19 to $21. At pricing, the company commands a fully diluted market value of $756 million.

Backed by Blackstone, Apria is a provider of integrated home healthcare equipment and related services in the US, with products and services for in-home care and delivery across three core service lines: home respiratory therapy (including home oxygen and non-invasive ventilation services); obstructive sleep apnea (OSA) treatment (including CPAP and bi-level positive airway pressure devices, and patient support services); and negative pressure wound therapy. In 2019, the company served nearly 2 million patients, made nearly 2.4 million deliveries, and conducted over 744,000 clinician interactions with patients.

Apria plans to list on the Nasdaq under the symbol APR. Citi, Goldman Sachs, BofA Securities and J.P. Morgan acted as lead managers on the deal.

The article Home healthcare equipment provider Apria prices IPO at $20 midpoint originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.